Back
Seres Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15
MCRB
Seres Therapeutics, Inc.
Last Price:
$14.92
Seasonality Move:
-18.39%
7 Day Trial
ALL ACCESS PASS
$
7
Seres Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Seres Therapeutics, Inc. has on average historically risen by 15.6% based on the past 10 years of stock performance.
-
Seres Therapeutics, Inc. has risen higher in 2 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
-
Is Seres Therapeutics, Inc. Stock Undervalued?The current Seres Therapeutics, Inc. [MCRB] share price is $14.98. The Score for MCRB is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
MCRB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Seres Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Seres Therapeutics, Inc. has on average historically risen by 15.6% based on the past 10 years of stock performance.
Seres Therapeutics, Inc. Stock Rating
Sell
15
Seres Therapeutics, Inc. (MCRB)
is a Sell
Is Seres Therapeutics, Inc. overpriced?
-
Seres Therapeutics, Inc. has risen higher in 2 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
Seres Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
serestherapeutics.com
52-Week Data
52-Week High:
29.98
52-Week Low:
6.53
Prediction Charts
Market Cap:
131.1M
Price in USD:
14.98
Volume:
169.7K
Beta:
2.07
Technical Analysis
SMA50:
17.40
SMA100:
17.62
SMA200:
14.12
52-Wk Change:
-18.67%
Stock Predictions
-
Is Seres Therapeutics, Inc. stock public?Yes, Seres Therapeutics, Inc. is a publicly traded company.
-
What is the Seres Therapeutics, Inc. stock quote today?The Seres Therapeutics, Inc. stock price is 14.98 USD today.
-
How to buy Seres Therapeutics, Inc. stock online?You can buy Seres Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 16.96 | 16.70 | 18.00 | 16.61 |
| Dec-3 | 16.96 | 17.44 | 17.95 | 16.87 |
| Dec-4 | 17.50 | 17.90 | 17.90 | 16.80 |
| Dec-5 | 17.78 | 16.66 | 17.90 | 16.53 |
| Dec-8 | 16.87 | 17.18 | 17.42 | 16.60 |
| Dec-9 | 17.03 | 16.78 | 17.52 | 16.55 |
| Dec-10 | 16.74 | 16.98 | 17.12 | 16.50 |
| Dec-11 | 17.08 | 17.16 | 17.30 | 16.95 |
| Dec-12 | 17.27 | 16.94 | 17.90 | 16.89 |
| Dec-15 | 17.02 | 15.90 | 17.45 | 15.68 |
| Dec-16 | 16.00 | 16.20 | 16.63 | 15.90 |
| Dec-17 | 16.33 | 15.44 | 16.33 | 15.35 |
| Dec-18 | 15.69 | 15.28 | 15.84 | 15.10 |
| Dec-19 | 15.22 | 14.98 | 15.79 | 14.03 |
Seres Therapeutics, Inc. Earnings
Seres Therapeutics, Inc. Earnings Report: Per Share Seres Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Seres Therapeutics, Inc. Forecast Revenue Growth
Seres Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Seres Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.94 per share, and a decrease next year of $11.20 per share.
* Seres Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.